Licepler (Eplerenone)

Eplerenone selectively blocks mineralocorticoid receptors in the distal tubules of the kidney, preventing aldosterone from promoting sodium reabsorption and potassium excretion. This results in increased sodium loss, modest diuresis, and a reduction in extracellular fluid volume, which together lower blood pressure and lessen harmful cardiac remodeling.

The dose of Licepler is individualized. The prescribing clinician determines the appropriate strength and dosing schedule based on the patient’s specific condition, kidney function, and any concomitant medications. No fixed regimen can be provided without a medical prescription.

Safety data for eplerenone in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the potential risk to the fetus. Breastfeeding mothers should consult their healthcare provider before use.

To request Licepler, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

The primary alternative to eplerenone is spironolactone, another aldosterone antagonist. Eplerenone is more selective for the mineralocorticoid receptor, resulting in fewer anti‑androgenic side effects such as gynecomastia. Both drugs lower blood pressure and improve heart‑failure outcomes, but eplerenone may be preferred when patients are sensitive to hormonal side effects.

Licepler should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat. Do not store in bathrooms or near kitchen appliances that generate steam.

Licepler is taken orally as a tablet. It can be swallowed whole with or without food, according to the prescribing information. Patients should follow the dosage schedule provided by their healthcare professional and not alter the timing or frequency without medical advice.

The most serious risks include severe hyperkalaemia, which can cause cardiac arrhythmias, acute renal impairment, and rare cases of angioedema. Patients should be educated to recognize symptoms such as muscle weakness, irregular heartbeat, swelling of the face or throat, and to seek immediate medical attention if they occur.

Licepler is contraindicated in patients with known hyperkalaemia, severe renal impairment (eGFR < 30 mL/min/1.73 m²), or those taking other potassium‑sparing agents that could raise serum potassium excessively. Caution is also advised for individuals with a history of angioedema or hypersensitivity to eplerenone.